Inspire Medical Systems (INSP)
(Delayed Data from NYSE)
$143.74 USD
+5.92 (4.30%)
Updated Jul 19, 2024 04:00 PM ET
4-Sell of 5 4
D Value B Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
INSP 143.74 +5.92(4.30%)
Will INSP be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for INSP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INSP
Inspire Medical (INSP) Dips on FDA Recall of IPG Model 3028
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
INSP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why Is Inspire (INSP) Down 7.3% Since Last Earnings Report?
Three Reasons to Retain Inspire Medical (INSP) Stock for Now
Other News for INSP
Inspire Medical Systems, Inc. Announces the Appointment of Melissa J. Mann as Chief People Officer
Inspire Medical Systems, Inc. Announces CE Mark Certification under the European Union’s Medical Device Regulation for Inspire Therapy
Inspire announces CE mark certification under EU MDR for Inspire Therapy
Inspire announces EU MDR approved additional MRI conditions for Inspire Therapy
Med-tech and healthcare stocks with upside during 2Q earnings - Baird